Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-09 Sale |
2021-02-10 8:17 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
35,000 | $6.75 | $236,250 | 837,000 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-09 4:00 pm |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
40,792 | $6.5 | $265,148 | 872,000 (Direct) |
View |
| 2020-08-18 Sale |
2020-08-19 08:55 am |
Aquestive Therapeutics Inc. | AQST | Maxwell John T. SVP-Chief Financial Officer |
3,000 | $8 | $24,000 | 150,614 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-15 Option Award |
2021-06-17 6:50 pm |
2022-06-15 2031-06-15 |
Aquestive Therapeutics Inc. | AQST | COSTA SANTO J Director |
20,000 | $0 | 37,327 (Direct) |
View |
| 2021-05-10 Gift |
2021-06-01 4:11 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
37,500 | $0 | 99,486 (Direct) |
View |
| 2021-03-09 Gift |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
62,500 | $0 | 7,220,655 (Direct) |
View |
| 2021-03-12 Other |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
5,259,492 | $0 | 7,220,655 (Indirect) |
View |
| 2021-03-12 Other |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
61,901 | $0 | 198,887 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Krop Julie Director |
28,500 | $0 | 28,500 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Interim CFO |
2,500 | $0 | 2,500 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Wood Theresa SVP-HR and Org. Development |
27,000 | $0 | 27,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Marshall Ken W. SVP, Chief Commercial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J SVP, General Counsel |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director |
28,500 | $0 | 28,500 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Barber Daniel SVP-Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-15 5:10 pm |
N/A 2031-03-11 |
Aquestive Therapeutics Inc. | AQST | Boyd Peter E. SVP-Bus. Process & Info. Tech. |
35,000 | $0 | 35,000 (Direct) |
View |
| 2020-12-30 Gift |
2021-01-04 4:05 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
1,000 | $0 | 638,149 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:00 pm |
2020-06-30 N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
333 | $0 | 912,792 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:00 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Schobel Alexander Mark Chief Innovation/Tech Officer |
94 | $4.86 | 912,792 (Direct) |
View |
| 2020-06-30 Exercise |
2020-07-02 4:00 pm |
2020-06-30 N/A |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
333 | $0 | 639,149 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:00 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | Kendall Keith J CEO and President |
148 | $4.86 | 639,149 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 5:12 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director |
14,000 | $0 | 89,085 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:05 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | Scibetta James S Director |
14,000 | $0 | 45,635 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:05 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | Lurker Nancy Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:05 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | COSTA SANTO J Director |
14,000 | $0 | 31,327 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:05 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K Director 10% Owner |
14,000 | $0 | 11,592,379 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:05 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | Cochran John Director |
14,000 | $0 | 89,085 (Direct) |
View |